CCLD.NASDAQCarecloud, INC

8-K: CareCloud Raises Guidance on Strong Q3 2025 Results

Sentiment:

Quarterly Results


CareCloud, Inc. announced strong third-quarter 2025 financial results, raising its full-year revenue guidance for the second time this year, driven by strategic acquisitions and AI initiatives.

Better than expectedFull-year 2025 revenue guidance was raised for the second time this year to $117-$119 million, exceeding previous expectations.Reported a 9% year-over-year revenue growth for Q3 2025, indicating strong operational performance.Achieved its sixth consecutive quarter of positive GAAP net income, demonstrating consistent profitability.Adjusted EBITDA increased by 13% year-over-year in Q3 2025 and 17% year-to-date 2025, reflecting improved operational efficiency.

Summary

  • Third-quarter 2025 revenue increased 9% year-over-year to $31.1 million.
  • Achieved GAAP Net Income of $3.1 million for Q3 2025, marking the sixth consecutive quarter of positive GAAP net income.
  • GAAP EPS improved by $0.08 year-over-year to $0.04 for Q3 2025.
  • Adjusted Net Income for Q3 2025 rose 27% year-over-year to $4.4 million.
  • Adjusted EBITDA for Q3 2025 increased 13% year-over-year to $7.7 million.
  • Year-to-date 2025 revenue grew 4% to $86.1 million.
  • Year-to-date 2025 GAAP Net Income surged 74% to $7.9 million.
  • Year-to-date 2025 GAAP EPS improved by $0.35 to $0.07.
  • Year-to-date 2025 Adjusted Net Income increased 50% to $10.0 million.
  • Year-to-date 2025 Adjusted EBITDA grew 17% to $19.9 million.
  • Full-year 2025 revenue guidance was raised for the second time to $117-$119 million, up from the initial range of $111-$114 million.
  • Full-year 2025 Adjusted EBITDA guidance is set at $26-$28 million.
  • Full-year 2025 EPS guidance is projected to be $0.10-$0.13.
  • Completed four strategic acquisitions this year, including Medsphere and Map App, expanding reach in the hospital market.
  • The AI Center of Excellence is now live and scaling, driving product innovation.
  • Reduced line of credit borrowing to $4.9 million from $8.3 million, funding the remaining balance of the $16.5 million Medsphere acquisition in cash.
  • Declared twelve consecutive months of Preferred Stock dividends, paid from internally generated free cash flow.

Sentiment

Score: 9

Explanation: The company reported exceptionally strong financial results, including significant revenue growth and sustained GAAP profitability. The decision to raise full-year revenue guidance for the second time, coupled with successful strategic acquisitions and scaling AI initiatives, indicates robust operational execution and a very positive outlook for future performance and shareholder value.

Positives

  • Full-year 2025 revenue guidance was raised for the second time, indicating strong ongoing business momentum and successful contributions from recent acquisitions.
  • Achieved its sixth consecutive quarter of positive GAAP net income, demonstrating sustained profitability.
  • Reported strong year-over-year growth in Q3 and year-to-date revenue, Adjusted Net Income, and Adjusted EBITDA.
  • Successfully completed four strategic acquisitions, including Medsphere and Map App, broadening market reach within the hospital sector.
  • The AI Center of Excellence is live and scaling, enhancing performance and efficiency through AI-driven innovation.
  • Reduced line of credit borrowing to $4.9 million from $8.3 million, reflecting strong cash flow generation and financial discipline.
  • Consistently paid twelve consecutive months of Preferred Stock dividends from internally generated free cash flow.

Risks

  • Ability to manage growth effectively.
  • Challenges in migrating newly acquired customers and retaining both new and existing customers.
  • Maintaining cost-effective global operations.
  • Increasing operational efficiency and reducing operating costs.
  • Predicting and properly adjusting to changes in reimbursement and other industry regulations and trends.
  • Retaining the services of key personnel.
  • Developing new technologies, and upgrading and adapting legacy and acquired technologies to work with evolving industry standards.
  • Competition from other companies' products and services.
  • Managing and keeping information systems secure.

Future Outlook

CareCloud is increasing its full-year 2025 revenue guidance for the second time this year to $117-$119 million, reflecting continued momentum from its core business and contributions from recent acquisitions. Adjusted EBITDA is expected to be $26-$28 million and EPS is projected to be $0.10-$0.13 for the full year 2025. The company anticipates continued growth through strategic acquisitions and scaling its AI initiatives.

Management Comments

  • Stephen Snyder, Co-Chief Executive Officer: "We are pleased to raise our full-year 2025 revenue guidance, marking another strong quarter of execution and growth for CareCloud. This performance extends our record of profitable expansion and reflects the positive impact of the Medsphere and Map App acquisitions, broadening our reach within the hospital market across both ambulatory and inpatient care settings."
  • A. Hadi Chaudhry, Co-Chief Executive Officer: "Our recent acquisitions and AI initiatives are working hand in hand to create meaningful value for our clients and shareholders. By infusing AI into acquired platforms, we're enhancing performance, driving efficiency, and opening new cross-sell and up-sell opportunities that strengthen CareCloud's long-term growth trajectory."
  • Norman Roth, Interim CFO and Corporate Controller: "This quarter marks a strategic milestone for CareCloud, with a combination of significant revenue growth along with GAAP profitability and strong cash flow from operations. This is our sixth consecutive quarter of positive GAAP net income and it is coupled with an increase in year-to-date revenue and adjusted EBITDA year over year."

Industry Context

CareCloud operates in the healthcare technology sector, which is increasingly driven by innovation in areas like generative AI and strategic consolidation through acquisitions. The company's focus on AI-driven solutions and expanding its market reach through acquisitions like Medsphere positions it to capitalize on trends towards enhanced operational efficiency and improved patient experience in both ambulatory and inpatient care settings. The continued growth and profitability suggest a strong competitive position within this evolving market.

Comparison to Industry Standards

  • NA

Stakeholder Impact

  • Shareholders (CCLD, CCLDO): Positive impact due to strong financial performance, raised guidance, sustained profitability, and consistent preferred stock dividend payments, potentially leading to increased share value and returns.
  • Clients: Enhanced value through the integration of AI into acquired platforms, leading to improved performance, efficiency, and a broader suite of healthcare technology solutions.
  • Employees: Strategic growth and AI initiatives may create new opportunities, though the filing also mentions restructuring costs, which could imply some workforce adjustments.

Next Steps

  • Continue to integrate recent acquisitions, such as Medsphere and Map App, to broaden market reach and enhance offerings.
  • Scale the AI Center of Excellence to drive further product innovation, efficiency, and cross-sell/up-sell opportunities.
  • Reinvest generated profits and cash reserves into future growth opportunities.
  • Host a conference call on November 6, 2025, to discuss results and 2025 growth strategies.

Key Dates

DateDescription
September 30, 2025End of the third fiscal quarter for which financial results are reported.
November 6, 2025Date of the 8-K report, press release, and earnings presentation. Also the date of the conference call.
December 31, 2025End of the fiscal year for which forward-looking guidance is provided.

Recommendation

strong buy

CareCloud demonstrated robust financial performance with significant year-over-year growth in revenue, adjusted net income, and adjusted EBITDA. The company achieved its sixth consecutive quarter of GAAP profitability and, notably, raised its full-year revenue guidance for the second time. Strategic acquisitions, including Medsphere, are successfully integrated and expanding market reach, while the scaling AI Center of Excellence promises future efficiency and value creation. The reduction in line of credit borrowing and consistent preferred stock dividend payments further underscore strong cash flow and financial discipline. These factors collectively indicate a strong growth trajectory and operational excellence, making it an attractive investment.

Keywords

Healthcare Technology, AI Solutions, Financial Results, Earnings Guidance, Acquisitions, Medsphere, CareCloud, Revenue Cycle Management, EHR, Adjusted EBITDA

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.